Structure Therapeutics (GPCR) Earnings Date & Reports

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

GPCR is expected to report earnings to fall 22.45% to -37 cents per share on November 18

Structure Therapeutics GPCR Stock Earnings Reports

Q3'26

Est.

$-0.38

Q2'26

Missed

by $0.12

Q1'26

Est.

$-0.35

Q4'25

Beat

by $0.45

Q3'25

Missed

by $0.10

The last earnings report on August 06 showed earnings per share of -49 cents, missing the estimate of -37 cents. With 402.95K shares outstanding, the current market capitalization sits at 2.50B.

View a ticker or compare two or three

GPCR

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for GPCR